Bioera SpA
MIL:BIE
Balance Sheet
Balance Sheet Decomposition
Bioera SpA
Bioera SpA
Balance Sheet
Bioera SpA
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
1
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Receivables |
12
|
12
|
12
|
11
|
10
|
7
|
4
|
2
|
1
|
1
|
|
| Accounts Receivables |
10
|
10
|
10
|
9
|
8
|
5
|
2
|
1
|
0
|
0
|
|
| Other Receivables |
3
|
2
|
2
|
2
|
2
|
2
|
3
|
1
|
1
|
1
|
|
| Inventory |
4
|
5
|
5
|
5
|
4
|
2
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
18
|
18
|
21
|
17
|
14
|
9
|
5
|
3
|
1
|
2
|
|
| PP&E Net |
3
|
4
|
4
|
4
|
4
|
3
|
3
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
11
|
11
|
8
|
7
|
6
|
6
|
6
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
0
|
2
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
4
|
4
|
4
|
2
|
2
|
10
|
2
|
0
|
|
| Other Long-Term Assets |
8
|
6
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Assets |
11
|
11
|
8
|
7
|
6
|
6
|
6
|
0
|
0
|
0
|
|
| Total Assets |
42
N/A
|
41
-1%
|
41
-1%
|
34
-17%
|
30
-13%
|
22
-27%
|
17
-23%
|
16
-2%
|
6
-65%
|
4
-32%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12
|
12
|
11
|
11
|
11
|
10
|
6
|
2
|
6
|
6
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
|
| Current Portion of Long-Term Debt |
2
|
7
|
9
|
8
|
6
|
6
|
6
|
4
|
0
|
0
|
|
| Other Current Liabilities |
3
|
3
|
3
|
3
|
3
|
4
|
5
|
4
|
8
|
8
|
|
| Total Current Liabilities |
17
|
22
|
22
|
22
|
20
|
20
|
18
|
10
|
18
|
19
|
|
| Long-Term Debt |
3
|
3
|
4
|
3
|
5
|
6
|
7
|
3
|
7
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
0
|
1
|
3
|
2
|
1
|
1
|
3
|
8
|
7
|
|
| Other Liabilities |
5
|
5
|
4
|
4
|
3
|
2
|
2
|
1
|
1
|
2
|
|
| Total Liabilities |
26
N/A
|
29
+12%
|
29
+0%
|
27
-9%
|
25
-7%
|
30
+22%
|
28
-7%
|
18
-37%
|
18
+3%
|
19
+4%
|
|
| Equity | |||||||||||
| Common Stock |
13
|
13
|
13
|
14
|
15
|
4
|
4
|
4
|
4
|
2
|
|
| Retained Earnings |
3
|
1
|
1
|
6
|
10
|
13
|
15
|
6
|
17
|
17
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
16
N/A
|
12
-23%
|
12
-4%
|
8
-36%
|
5
-33%
|
8
N/A
|
11
-33%
|
1
+89%
|
13
-895%
|
15
-20%
|
|
| Total Liabilities & Equity |
42
N/A
|
41
-1%
|
41
-1%
|
34
-17%
|
30
-13%
|
22
-27%
|
17
-23%
|
16
-2%
|
6
-65%
|
4
-32%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
4
|
0
|
1
|
1
|
1
|
2
|
4
|
4
|
21
|
|